-
1.
公开(公告)号:US10858392B2
公开(公告)日:2020-12-08
申请号:US15660373
申请日:2017-07-26
Applicant: Kaneka Corporation
Inventor: Shinichi Yoshida , Dai Murata
IPC: C07K1/22 , C07K14/315 , C07K16/00 , C07K17/00 , C07K16/10
Abstract: An affinity separation matrix includes a water-insoluble base material; and a ligand that is immobilized on the water-insoluble base material, wherein the ligand is an antibody κ chain variable region-binding peptide comprising B5 domain of Protein L derived from Peptostreptococcus magnus 312 strain or a part thereof.
-
公开(公告)号:US10774115B2
公开(公告)日:2020-09-15
申请号:US15686666
申请日:2017-08-25
Applicant: Kaneka Corporation
Inventor: Shinichi Yoshida
IPC: C07K14/31 , C07K14/315 , C12N15/09 , G01N30/88 , C07K16/24 , A61K39/44 , A61K38/00 , A61K39/00 , C07K19/00 , B01J20/289 , B01J20/32 , B01D15/38
Abstract: A first Fab region-binding peptide includes an amino acid sequence selected from the group consisting of SEQ ID NOs: 1 to 5 with substitution of one or more amino acid residues at the 17th position and the 36th position, wherein an acid dissociation pH thereof is shifted to a neutral side. A second Fab region-binding peptide further includes deletion, substitution and/or addition of one or more amino acid residues at positions other than the 17th position and the 36th position. A third Fab region-binding peptide includes an amino acid sequence with a sequence identity of 80% or more to the amino acid sequence of the first Fab region-binding peptide.
-
公开(公告)号:US20180215835A1
公开(公告)日:2018-08-02
申请号:US15876604
申请日:2018-01-22
Applicant: Kaneka Corporation
Inventor: Masakatsu Nishihachijyo , Yoshiyuki Nakano , Fuminori Konoike , Masayuki Takano , Shinichi Yoshida , Kazunobu Minakuchi
CPC classification number: C07K17/02 , B01D15/3809 , C07B2200/11 , C07K1/22 , C07K14/31 , C07K16/065 , C07K2317/52 , C07K2317/92 , C07K2318/20
Abstract: A protein includes an amino acid sequence derived from the sequence of SEQ ID NO: 1, wherein the amino acid sequence includes a substitution of Val at a position corresponding to position 40 of SEQ ID NO: 1 with a polar uncharged amino acid residue, a basic amino acid residue, or Ala. The protein has a reduced antibody-binding capacity in an acidic pH range, as compared to a protein including the amino acid sequence without the substitution.
-
公开(公告)号:US20180016306A1
公开(公告)日:2018-01-18
申请号:US15660365
申请日:2017-07-26
Applicant: Kaneka Corporation
Inventor: Shinichi Yoshida
IPC: C07K14/195 , C07K16/00 , C07K1/22 , C07K16/10 , C07K17/00
Abstract: A first immunoglobulin κ chain variable region-binding peptide includes an amino acid sequence of SEQ ID NO: 21 with substitution of one or more amino acid residues at the 15th position, the 16th position, the 17th position or the 18th position, wherein an acid dissociation pH thereof is shifted to a neutral side. A second immunoglobulin κ chain variable region-binding peptide further includes deletion, substitution and/or addition of 1-20 amino acid residues at positions other than the 15th position, the 16th position, the 17th position and the 18th position. A third immunoglobulin κ chain variable region-binding peptide includes an amino acid sequence with a sequence identity of 80% or more to the amino acid sequence of the first immunoglobulin κ chain variable region-binding peptide.
-
5.
公开(公告)号:US20170327535A1
公开(公告)日:2017-11-16
申请号:US15660373
申请日:2017-07-26
Applicant: Kaneka Corporation
Inventor: Shinichi Yoshida , Dai Murata
CPC classification number: C07K1/22 , C07K14/315 , C07K16/00 , C07K16/1027 , C07K17/00 , C07K2317/55
Abstract: An affinity separation matrix includes a water-insoluble base material; and a ligand that is immobilized on the water-insoluble base material, wherein the ligand is an antibody κ chain variable region-binding peptide comprising B5 domain of Protein L derived from Peptostreptococcus magnus 312 strain or a part thereof.
-
公开(公告)号:US10556944B2
公开(公告)日:2020-02-11
申请号:US14914439
申请日:2014-08-28
Applicant: KANEKA CORPORATION
Inventor: Shinichi Yoshida , Dai Murata
IPC: C07K16/12 , C07K14/315 , C07K1/22
Abstract: An object of the present invention is to provide a Fab region-binding peptide having an excellent ability for binding to a Fab region of IgG, an affinity separation matrix having the peptide as a ligand, and a method for producing a Fab region-containing protein, the method using the affinity separation matrix. Further, another object of the present invention is to provide a DNA encoding for the peptide, a vector containing the DNA, and a transformant which has been transformed by the vector. The Fab region-binding peptide according to the present invention is characterized in having a mutation at a specific site in comparison with wild-type SpG-β1.
-
7.
公开(公告)号:US20190263870A1
公开(公告)日:2019-08-29
申请号:US16298639
申请日:2019-03-11
Applicant: KANEKA CORPORATION
Inventor: Shinichi Yoshida , Dai Murata , Shunichi Taira , Masayuki Takano , Keita Iguchi , Yoshiyuki Nakano
IPC: C07K14/195 , C07K16/32 , C07K14/31 , C07K16/06 , C07K1/22
Abstract: An object of the present invention is to create a novel engineered Protein A ligand having better antibody dissociation properties in the acidic condition compared with known engineered Protein A ligands. The present invention provides a protein having an affinity for an immunoglobulin, including an amino acid sequence obtained by introducing, into an amino acid sequence derived from any of E, D, A, B and C domains of Protein A, at least one amino acid substitution at any one or more of amino acid residues corresponding to positions 31 to 37 of the A, B and C domains (positions 29 to 35 of the E domain, positions 34 to 40 of the D domain), which are conserved in all the domains, the protein having a lower affinity for an Fab region of an immunoglobulin than a protein having the amino acid sequence before introduction of the substitution.
-
公开(公告)号:US20190153072A1
公开(公告)日:2019-05-23
申请号:US16259174
申请日:2019-01-28
Applicant: KANEKA CORPORATION
Inventor: Dai Murata , Shinichi Yoshida
Abstract: A method for producing an antibody fragment includes preparing a liquid sample that includes the antibody fragment and does not include an Fc fragment, adsorbing the antibody fragment on an affinity separation matrix by contacting the liquid sample with the affinity separation matrix, removing impurities from the affinity separation matrix by washing the affinity separation matrix, and separating the antibody fragment from the affinity separation matrix. The antibody fragment includes a CH1 region and does not include an Fc region. The affinity separation matrix includes a water-insoluble carrier and a ligand immobilized on the water-insoluble carrier. The ligand is Protein G, a Protein G domain, a Protein G variant or a Protein G domain variant.
-
公开(公告)号:US20190119362A1
公开(公告)日:2019-04-25
申请号:US16176090
申请日:2018-10-31
Applicant: KANEKA CORPORATION
Inventor: Shinichi Yoshida , Dai Murata
Abstract: A method for producing a protein includes adsorbing a protein including a κ chain variable region on an insoluble carrier of an affinity separation matrix by contacting a liquid sample including the protein with the affinity separation matrix; washing the affinity separation matrix to remove impurities; separating the protein from the affinity separation matrix by using an acidic buffer; and regenerating the affinity separation matrix by using an alkaline aqueous solution after the protein is separated from the affinity separation matrix. The insoluble carrier includes a ligand immobilized on the insoluble carrier, and the ligand is a κ chain variable region-binding peptide including B5 domain of Protein L derived from Peptostreptococcus magnus 312 strain or a variant of the B5 domain. The adsorbing, the washing, and the separating are repeated 3 or more times.
-
公开(公告)号:US20180215785A1
公开(公告)日:2018-08-02
申请号:US15876615
申请日:2018-01-22
Applicant: Kaneka Corporation
Inventor: Masakatsu Nishihachijyo , Yoshiyuki Nakano , Fuminori Konoike , Masayuki Takano , Shinichi Yoshida , Kazunobu Minakuchi
CPC classification number: C07K1/22 , B01D15/168 , B01D15/3809 , B01J20/286 , B01J20/3212 , B01J20/3219 , B01J20/3274 , C07K14/31 , C07K17/02
Abstract: A method for purifying an antibody-like protein includes adsorbing an antibody-like protein onto an affinity separation matrix by bringing the antibody-like protein into contact with the affinity separation matrix; and eluting the antibody-like protein by bringing an eluent having a pH of 3.5 or higher into contact with the affinity separation matrix. The affinity separation matrix includes a carrier and a ligand immobilized on the carrier, and the ligand includes an amino acid sequence derived from a sequence selected from the group consisting of SEQ ID Nos: 1 to 5. Gln or Lys in an Fc-binding site of the amino acid sequence is substituted by Ala, Ser, or Thr, and the ligand has a lower antibody-binding capacity in an acidic pH range, as compared to a ligand including the amino acid sequence without the substitution.
-
-
-
-
-
-
-
-
-